<!DOCTYPE html>
<html lang="es">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Publications - Javier Lanillos-Manchón</title>
    <link rel="stylesheet" href="../css/style.css">
    <style>
        /* Basic Dropdown Styling */
        .dropdown {
            background-color: transparent; /* Remove the green background */
            color: #30525f; /* Title color same as header */
            padding: 10px;
            cursor: pointer;
            width: 100%;
            text-align: left;
            border: none;
            font-size: 18px;
            font-weight: bold;
            margin: 10px 0;
        }

        .dropdown-content {
            display: none; /* Start hidden */
            background-color: #f4f4f4; /* Light background for dropdown */
            padding: 10px;
            border-radius: 5px;
            margin-top: 10px;
        }

        .dropdown-content article {
            margin-bottom: 20px;
        }

        .dropdown-content a {
            color: #1a1b3a;
            text-decoration: none;
        }

        .dropdown-content a:hover {
            text-decoration: underline;
        }

        /* Optional: style to indicate expanded sections */
        .expanded {
            background-color: #e7f5e7; /* Light green when expanded */
        }

        /* Add some padding to the main content */
        main {
            padding: 20px;
        }
    </style>
</head>
<body>
    <header>
        <h1>Publications</h1>
        <nav>
            <ul>
                <li><a href="../index.html">Introduction</a></li>
                <li><a href="research.html">Research</a></li>
                <li><a href="publications.html">Publications</a></li>
                <li><a href="skills.html">Skills</a></li>
            </ul>
        </nav>
    </header>

    <main>
        <section>
            <h2>Bioinformatics helped me to learn how to collaborate</h2>
            <!-- Dropdown for Highlighted Publications -->
            <button class="dropdown">First-author publications presented in my PhD thesis <span class="arrow">▶</span></button>
            <div class="dropdown-content">

                <article>
                    <ul>
                        <li><a href="https://www.mdpi.com/2077-0383/9/7/2082">A Novel Approach for the Identification of Pharmacogenetic Variants in MT-RNR1 through Next-Generation Sequencing Off-Target Data</a></li>
                        <p>This work proved that actionable mitochondrial DNA genetic variants can be genotyped using off-target reads from capture-hybrid technologies. A collaboration with a private company was established to accelerate this research, letting us to access a new and unexplored dataset.</p>

                    </ul>
                </article>

                <article>
                    <ul>
                        <li><a href="https://pubmed.ncbi.nlm.nih.gov/35688666/">Interrogating the Significance of PARP1 Expression and PBRM1 Mutation as Biomarkers for Predicting the Response to Atezolizumab plus Bevacizumab or to Sunitinib in Patients with Clear Cell Renal Cell Carcinoma</a></li>
                        <p>This work made use of clinical multi-omics datasets from clinical trials to explore new biomarkers for kidney cancer immunotherapy. This project highlights the engineering ability to connect dots between a new piece of clinical evidence and the possibility to test it in other datasets.</p>

                    </ul>
                </article>

                <article>
                    <ul>
                        <li><a href="https://pubmed.ncbi.nlm.nih.gov/35181665/">Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data</a></li>
                        <p>Comprehensive study of all pharmacogenes that could be clinically actionable repurposing whole exome sequencing. We established a collaboration with private company to increase the value of whole exome in the clinics. This work uncovered population pharmacogenomics data from individuals in Spain and South American countries.</p>
                    </ul>
                </article>

            </div>

            <!-- Dropdown for Highlighted Publications -->
            <button class="dropdown">OHighlighted Publications - Traslational pharmacogenomics <span class="arrow">▶</span></button>
            <div class="dropdown-content">

                <article>
                    <ul>
                        <li><a href="'https://www.nature.com/articles/s43018-023-00721-w'">Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma</a></li>
                        <p>As part of my 3-month visit to Reznik's lab at MSKCC, we contributed with the transcriptomics analysis of the Hartwig Medical Foundation cohort.This exemplifies the effort to uncover novel genetics insides from publicly available datasets.</p>
                    </ul>
                </article>

                <article>
                    <ul>
                        <li><a href="https://www.sciencedirect.com/science/article/pii/S1098360021024679">Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma</a></li>
                        <p>This is a great example of the teamwork between clinicians, experimental researchers and bioinformaticians. I contrbuted with the analysis of gene panel sequencing to uncover that papillary type 2 or unknown histology patients should be screened for FH mutation.</p>

                    </ul>
                </article>

                <article>
                    <ul>
                        <li><a href="#https://www.nature.com/articles/s41379-020-0607-z">Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome</a></li>
                        <p>This study let me learn about chRCC genetics, increase my interest on mitochondrial DNA genetics and collaborate in an experimental and clinical environment.</p>
                    </ul>
                </article>

                <article>
                    <ul>
                        <li><a href="https://pubmed.ncbi.nlm.nih.gov/31403184/">PTEN expression and mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with renal cell carcinoma</a></li>
                        <p>This study let me understand the combination of histology and sequencing technologies to derive into response biomarkers in renal cancer therapy.</p>
                    </ul>
                </article>

                <article>
                    <ul>
                        <li><a href="https://pubmed.ncbi.nlm.nih.gov/37260183/">Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition</a></li>
                        <p>Few extraordinary responses observed in patients led to detect USP9X mutations to be associated with mTOR inhibition, boosting precision medicine in these patients.</p>
                    </ul>
                </article>

                <article>
                    <ul>
                        <li><a href="https://pubmed.ncbi.nlm.nih.gov/37293154/">PBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer</a></li>
                        <p>Enhancing my knowledge on the role of angiogenesis in renal cancer and key driver genes associated to drug response.</p>
                    </ul>
                </article>

            </div>

            <!-- Dropdown for Other Collaborations -->
            <button class="dropdown">Other Collaborations within Genomics Medicine <span class="arrow">▶</span></button>
            <div class="dropdown-content">

                <article>
                    <ul>
                        <li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6691382/">Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma</a></li>
                        <p>This study uncovers a miRNA signature linked to prognosis in metastatic pheochromocytoma/paraganglioma and identifies the miR-21-3p/TSC2/mTOR axis as a potential therapeutic target.</p>
                    </ul>
                </article>

                <article>
                    <ul>
                        <li><a href="https://www.nature.com/articles/s41467-023-36769-6">Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma</a></li>
                        <p>This research delineates the genomic alterations and immune profiles characteristic of metastatic pheochromocytoma and paraganglioma.</p>
                    </ul>
                </article>

                <article>
                    <ul>
                        <li><a href="https://pubmed.ncbi.nlm.nih.gov/31403184/">Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing</a></li>
                        <p>This article was key to understand better the genetic basis of thyroid cancer.</p>
                    </ul>
                </article>


                <article>
                    <ul>
                        <li><a href="https://pubmed.ncbi.nlm.nih.gov/34190375/">Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial</a></li>
                        <p>This clinical trial evaluates the efficacy of combining Sunitinib and Evofosfamide in treatment-naïve patients with metastatic pancreatic neuroendocrine tumors.</p>
                    </ul>
                </article>

                <article>
                    <ul>
                        <li><a href="https://pubmed.ncbi.nlm.nih.gov/33182397/">Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma</a></li>
                        <p>This case report identifies a novel germline DNMT3A mutation in a patient presenting with multiple paragangliomas and papillary thyroid carcinoma.</p>
                    </ul>
                </article>

                <article>
                    <ul>
                        <li><a href="https://pubmed.ncbi.nlm.nih.gov/32791518/">CD133 expression in medullary thyroid cancer cells identifies patients with poor prognosis</a></li>
                        <p>This research associates CD133 expression in medullary thyroid cancer cells with poorer patient outcomes.</p>
                    </ul>
                </article>


                <article>
                    <ul>
                        <li><a href="https://link.springer.com/content/pdf/10.1186/s13023-021-02079-7.pdf">Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients</a></li>
                        <p>This research provides insights into the diagnosis and monitoring of PTEN hamartoma tumor syndrome through a clinical and genetic study of Spanish patients.</p>
                    </ul>
                </article>


                <article>
                    <ul>
                        <li><a href="https://pubmed.ncbi.nlm.nih.gov/37139660/">DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling</a></li>
                        <p>This research indicates that DLST mutations in pheochromocytoma and paraganglioma lead to reduced protein succinylation and metabolic changes.</p>
                    </ul>
                </article>
            </div>
        </section>
        
    </main>

    <footer>
        <p>Contacto: <a href="mailto:javier.lanillos@ibb.csic.es">javier.lanillos@ibb.csic.es</a> ORCID: <a href="https://orcid.org/0000-0002-5054-6007" target="_blank">0000-0002-5054-6007</a></p>
        <img src="../images/CSIC_LOGO.svg" alt="Kindly generated by Dr. Emilio José" style="display: block; margin: 20px auto; max-width: 200px;">
    </footer>

    <script>
        document.querySelectorAll('.dropdown').forEach(function(button) {
            button.addEventListener('click', function() {
                const content = button.nextElementSibling;
                const arrow = button.querySelector('.arrow');
                
                if (button.classList.contains('expanded')) {
                    content.style.display = "none";
                    button.classList.remove('expanded');
                    arrow.textContent = "▶"; // Right arrow when collapsed
                } else {
                    content.style.display = "block";
                    button.classList.add('expanded');
                    arrow.textContent = "▼"; // Down arrow when expanded
                }
            });
        });
    </script>
</body>
</html>
